Introduction {#S1}
============

Bacteria and archaea are constantly challenged by invasive genetic elements (e.g. bacteriophage, transposons, and plasmids). To combat these threats, prokaryotes evolved an adaptive immune system known as CRISPR-Cas (clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins)^[@R1]--[@R4]^. This immune system is able to capture foreign genetic elements into repeats in the CRISPR loci as short DNA segments. These captured "spacer" sequences are expressed in the context of precursor CRISPR RNAs (pre-crRNAs), which are processed into small CRISPR RNAs (referred to as guide RNAs or gRNAs)^[@R1]--[@R4]^. CRISPR-Cas proteins use the gRNA complementarity and often a protospacer adjacent motif (PAM) to recognize and cleave the target thus conferring immunity to the invading elements^[@R1]--[@R4]^. The CRISPR-Cas systems have been adapted as versatile genome editing tools that are ubiquitously used in many disciplines^[@R5]^.

*Strepotococcus pyogenes* Cas9 is a type II-A CRISPR-Cas nuclease that is widely studied and used in genome editing and epigenome manipulation^[@R6],[@R7]^. Cas9 is a blunt cutting nuclease that can target specific DNA sequences using a NGG PAM and a gRNA^[@R8]^. Many variants of Cas9 have been developed (e.g. transcription activating/repressing, nicking, nuclease-dead, base editing etc.)^[@R9]--[@R11]^. One set of observations of particular note in reference to such variants are experiments in which nicking of targets can be used to guide homology-dependent gene editing, with apparent advantages in specificity^[@R12]^ and efficiency^[@R13]^ over double stranded break strategies. These assessments were carried out with mutant variants of Cas9 in which one of the nuclease domains has been inactivated. Sternberg et al.^[@R14]^ describe a conformational shift mechanism which would arguably coordinate the two nuclease domains to provide concerted double strand cleavage without substantial accumulation of nicked intermediates, while Szczelkun et al.^[@R15]^ ([Figure 6Sb](#SD1){ref-type="supplementary-material"}) describe one case of a truncated gRNA:target match that leads to slower coordination and accumulation *in vitro* of a nicked substrate. In addition, Strohkendl et al.^[@R16]^ reported temporary nicking with Cpf1 due to mismatches influencing the timescale of cleavage of each DNA strand.

Cpf1 is a minimal type V CRISPR-Cas nuclease that uses a single Cas endonuclease paired with a gRNA to cleave complementary DNA targets^[@R17]--[@R20]^. Cpf1 homologs from three species have been successfully adapted for genome editing: *Acidaminococcus sp*. (AsCpf1), *Francisella novicida* (FnCpf1), and *Lachnospiraceae bacterium* (LbCpf1)^[@R18]^. Cpf1 homologs recognizes T-rich PAMs (reported as TTTN/TTTV for As/Lb-Cpf1 and TTV for FnCpf1, theoretically opening a wide array of sites not available for Cas9 editing^[@R17],[@R21]^. Cpf1 processes its own pre-CRISPR RNA, allowing this to be a potential platform for multi-gene functional analysis^[@R21],[@R22]^. Despite numerous possible advantages, Cpf1 homologs have yet to be used as extensively in genome editing applications as Cas9.

Examining the consequences of Cpf1 and Cas9 activities on DNA topology for a broad set of potential substrates, we observed efficient nicking activities with both nucleases on specific classes of mismatched DNA targets. Given that either nicking or double stranded cleavage of DNA is sufficient to induce a variety of repair and replacement mechanisms *in vivo*^[@R13],[@R23]--[@R27]^, the resulting profiles illuminate a dual capability of CRISPR-Cas nucleases to initiate genetic change through both types of interaction. These observations challenge binary models in which CRISPR-Cas9 nucleases either cleave or fail to cleave individual targets. Instead, our data indicate a scenario in which cleaving and nicking targets can and will coexist in a single experimental or natural condition.

Results {#S2}
=======

Sequence dependence for CRISPR-Cas nuclease activity was first addressed by building variant libraries of plasmids with a diversity of perfectly matched ("wild-type") and mismatched ("mutant") target sequences. Each sequence (wild-type or mutant) is represented by several barcoded species. We challenged the variant library with CRISPR-Cas nuclease protein programmed with single gRNA, and used sequencing to determine which templates remained following nuclease treatment. Additional information on the nature of the cleaved substrates comes from assays with and without a whole-library (backbone) linearization step after CRISPR-Cas nuclease cleavage of substrates and before PCR ([Figure 1a](#F1){ref-type="fig"}). In particular, we note that backbone-intact assays provide a potential to distinguish nicked from closed circles due to the higher PCR yields observed from molecules where a nicking event has allowed the two plasmid strands to become topologically unlinked^[@R28]^.

Cpf1 nicking and cleavage specificity {#S3}
-------------------------------------

Sequence dependence for LbCpf1 activity was investigated using a variant library of plasmids for four different canonical guide sequences: EGFP-1, EGFP-2, *unc-22A*, and *rol-6* ([Figure 1b](#F1){ref-type="fig"}). Initial assays were carried out with the backbone-linearization step (Method 1, [Figure 1a](#F1){ref-type="fig"}). For each target, the libraries contained unmodified sequences, single-base variants, double-adjacent transversions, and deletions. Using loss-of-amplification across the cleavage junction as an assay, LbCpf1 showed a similar specificity profile to previous characterizations of Cas9, less tolerance of mutations in the seed region (positions 1--10, with position 1 being PAM-proximal) while sequence requirements in the distal region (positions 11--20) were more lax (left panel of [Figure 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}; left panel of [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}--[6](#SD1){ref-type="supplementary-material"}). This trend is consistent for all three classes of variants, for all Cpf1s, and on all tested targets (left panel of [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}--[6](#SD1){ref-type="supplementary-material"}).

An unexpected feature of Cpf1 cleavage was observed in assays with the circular variant library in which no linearization was carried out before assessing retention (Method 2). Certain target site variants had highly positive retention scores, which suggest these variants increase (rather than decrease) their representation during a short-time cleavage reaction. Log-retention scores were observed as high as \~3 (i.e., 2^3^ or 8-fold enrichment) for double mutants from time points 1,3, 10, and 30 minutes (right panels of LbCpf1: [Figure 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}; AsCpf1 and FnCpf1: [Supplementary Figures 7](#SD1){ref-type="supplementary-material"}--[27](#SD1){ref-type="supplementary-material"}). For some targets, these effects disappeared at longer reaction times, as expected if there was eventual cleavage of the circular targets ([Figure 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}). The enhanced recovery led to the hypothesis of a rapid nicking of the initial substrate followed by a relatively slow cleavage on the opposite strand (nicked plasmids enhance PCR amplification compared to linear and supercoiled substrates^[@R28]^). This would explain the observed over-representation after addition of Cpf1 and the highly positive retention score followed by much slower loss of the observed retention.

The nicking hypothesis was tested by reacting Cpf1::gRNA complexes with individual plasmid substrates and examining topology using ethidium-containing native agarose DNA gels. Sequence variants with highly positive retentions were identified in the high throughput data and either cloned into a DNA plasmid or synthesized as a gRNA. Using a DNA target with double-consecutive transversion mutations in positions 12--13 and 14--15 in wild-type EGFP-1 gRNA, we found LbCpf1 was rapidly capable of converting closed circular to nicked circular substrates in these assays ([Figure 4a](#F4){ref-type="fig"}--[b](#F4){ref-type="fig"}). In addition, the nicking ability was found to be specific, with no observed nicking of substrates lacking homology to the gRNA ([Figure 4c](#F4){ref-type="fig"}). The nicking ability was confirmed in AsCpf1 and FnCpf1 with their respective EGFP-1 gRNAs ([Supplementary Figure 28](#SD1){ref-type="supplementary-material"}--[29](#SD1){ref-type="supplementary-material"}).

To evaluate the determinants for nicking and cleavage, we carried out a number of reciprocal experiments in which mutated gRNAs were used in assays with wild-type targets. These assays showed nicking and some linearization, as expected if the ability to form a nicking enzyme is a general feature of certain classes of gRNA::target mismatch. We note that there was some non-equivalence in the target-mutated versus gRNA-mutated assays, depending on the individual gRNAs ([Supplementary Figure 30](#SD1){ref-type="supplementary-material"}). These data indicate an interaction in which specific sequence along with the pattern of mismatches determine the balance between nicking and cleavage activities.

The above observations raise the possibility that an appropriately designed gRNA might produce effective single-strand nicking activity on an arbitrary substrate. Some possible guidelines for such design are suggested from the patterns of mismatch effects on initial sequence recovery in [Figures 2](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"} and [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}--[6](#SD1){ref-type="supplementary-material"}. In particular, we see a strong tendency to nick for templates with a combination of transversion point mutations in the distal region (positions 9--15). Taking consecutive double mutation at positions 12 and 13 as a provisional lead for such assays, we first tested the ability to produce nicking activities towards additional targets where no high throughput analysis of target specificity had been carried out (targets dm22085 (DNMT1), fc596 (FANCF) and wp1058 (WTAP)). While these three sequences show different degrees of cleavage for matched gRNA:target combinations, all three bias toward nicking with the indicated double mutant target ([Supplementary Figure 31](#SD1){ref-type="supplementary-material"}--[33](#SD1){ref-type="supplementary-material"}).

Cas9 nicking and cleavage specificity {#S4}
-------------------------------------

The type II CRISPR effector enzyme Cas9 has been a workhorse tool for genome editing and for a wide variety of experimental applications *in vitro* and *in vivo*. We tested *S. pyogenes* Cas9 for nicking activity in assays and libraries that (as with the tested Cpf1 libraries) contained wild-type, single variants, single deletions, and double consecutive mutations in four targets: EGFP-1, EGFP-2, *unc-22A*, and *rol-6* ([Figure 1b](#F1){ref-type="fig"}). While yielding some evidence of preferential nicking of specific substrates, these assays yielded a less dramatic distinction between nicking and double strand cleavage for individual template sequences than had been seen with Cpf1 ([Supplementary Figure 34](#SD1){ref-type="supplementary-material"}--[45](#SD1){ref-type="supplementary-material"}). Encouraged by the differences (but with the knowledge that an optimal nicking activity might require more extensive mutational analysis), we repeated the Cas9 assays using an *unc-22A* library obtained through random oligonucleotide synthesis with a broader set of multiple mutations (Fu et al.^[@R29],[@R30]^; [Supplementary Figure 46](#SD1){ref-type="supplementary-material"}). These assays showed a strong preferential nicking for a variety of double mutants ([Supplementary Figure 47](#SD1){ref-type="supplementary-material"}). Examining an extended list of the randomly mutagenized targets from this library for which positive retention scores indicated a strong nicking activity ([Supplementary Table 1](#SD3){ref-type="supplementary-material"}), we chose a design with two mutations, a single deletion in the seed region at position 5 and a mismatch (A to G) in the distal region at position 18 for the *unc-22A* target. DNA templates with this double variant reacted with Cas9 complexed to wild-type *unc-22A* gRNA confirmed robust target specific nicking ([Figure 4d](#F4){ref-type="fig"}). EGFP-2 variant targets that had a highly positive retention score in the high throughput assays were likewise confirmed as nicking substrates in agarose gel assays ([Figure 4e](#F4){ref-type="fig"}). Conversely, wild-type *unc-22A* and EGFP-2 targets were assayed for nicking with the equivalently mismatched (mutant) gRNA. Similar to Cpf1, the equivalent mutations in the gRNA with wild-type targets showed nicking and some linearization that varied depending on gRNAs ([Supplementary Figure 48](#SD1){ref-type="supplementary-material"}--[49](#SD1){ref-type="supplementary-material"}). Finally, we observed that some non-intended targets were nicked (e.g. a variant target sequence of *unc-22A* nicking with wild-type EGFP-2 gRNA). We hypothesized that targets with certain minimal and/or broken homologies can induce nicking. We confirmed this by testing non-targeting DNA with gRNAs that showed positive retention scores and confirmed the nicking observed in the high throughput results. For example, we observed in the high throughput assays a variant of the *unc-22A* target that evidently nicks with EGFP-2 gRNA ([Supplementary Figure 50](#SD1){ref-type="supplementary-material"}). This variant brings the *unc-22A* sequence somewhat closer to the EGFP-2 sequence, although still providing rather limited homology (contiguous complementarity confined to 6 consecutive matches in the seed region). While demonstrating a less stringent sequence requirement, nicking remained a specific process, with only residual nicking for unrelated targets observed in the gel assay (e.g., \>16-hour time point, [Supplementary Figure 51](#SD1){ref-type="supplementary-material"}).

Tuning of relative nicking activity {#S5}
-----------------------------------

Analysis of complex libraries at multiple time points or with differing enzyme:substrate ratios provides a combined view that allows selection of substrates with a high preference for nicking over cleavage, with little or no cleavage even on extended incubation. Such substrates are exemplified for Cas9 by *unc-22A* double transversion (positions 5,12) ([Supplementary Figure 47](#SD1){ref-type="supplementary-material"}). For LbCpf1 maximal nicking is seen at certain time points with double consecutive transversion mutations in positions (12/13 and 14/15; [Figure 3](#F3){ref-type="fig"}, [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}--[6](#SD1){ref-type="supplementary-material"}). These examples illustrate the value of an optimization round in identifying the most specific nicking reagents for a given target, and of the value of a broad variant survey in characterizing potential off-target nicking consequences for a given gRNA.

Nicking in vivo in S. cerevisiae {#S6}
--------------------------------

Assessments of Cas9 activity *in vivo* were carried out in *S. cerevisiae*, using methodologies of Cas9 and gRNA expression and of target library production described in Fu et al.^[@R30]^. These high throughput assays allow tracking of topology as a function of sequence for a target library, allowing determination of which templates in a complex pool are cut, which are nicked, and which are not cut. Assays in yeast allow assessment of nuclease activities in a system with rapid cell division and where the DNA targets are present in a chromatinized context (in contrast to the supercoiled plasmid context of the above assays, which may be much more representative of bacterial than of eukaryotic chromosomes).

While sequencing provides a valuable assay for determining the population of molecules present before and after exposure *in vivo* to a Cas9+gRNA pair, it remains important to approach such data with considerable care. One concern is that the *in vivo* situation in yeast will represent a dynamic equilibrium between any cleavage or nicking by the Cas9 enzyme and repair processes (that might fix a nick or break) or other cellular processes (e.g. replication across a nick, generating a break) that might interconvert the various states. To investigate *in vivo* activities, we evaluated the incidence of nicked substrates *in vivo* rather than the much more complicated kinetic question of determining the rate of new nicks in the presence of repair and other activities.

In developing assays to test nicking of DNA *in vivo*, the simple detection of relaxed circles among extracted DNAs is not sufficient to infer whether nicking had occurred *in vivo*, or nicking occurred during extraction and/or analysis of DNA. To ensure definitive resolution of this issue, we asked a number of additional questions. Is the nicking signal (enhanced PCR yield observed in DNA pools containing close matches to the guide) is reproducible in parallel samples and in different biological backgrounds? Is the nicking signal specific to molecules in the target pool with homology to the Cas9 gRNA and PAM site? For partially-matched targets, the nicking signal decrease for target sequences with substantial numbers of gRNA mismatches? Does the nicking signal increase with induction of Cas9 and with longer exposure times *in vivo*? Does the *in vivo* nicking signal for different target variants correlate with measured *in vitro* nicking?

Our analysis found all the criteria fulfilled. The nicking signal (preferential retention of gRNA-matched targets in samples processed from uncut yeast DNA) is consistent between replicates of induced yeast ([Figure 5a](#F5){ref-type="fig"}), depends on both PAM sequence and gRNA homology ([Figure 5a](#F5){ref-type="fig"}--[c](#F5){ref-type="fig"}), is lost with multiple mutations in the target ([Figure 5b](#F5){ref-type="fig"}--[c](#F5){ref-type="fig"} 4--7 mismatch lane), increases with longer exposure times ([Figure 5b](#F5){ref-type="fig"}--[c](#F5){ref-type="fig"}, comparing single-generation and 2.5 generation samples), and is correlated (R=0.47, p-value=0.00015; n=66) with nicking observed *in vitro* ([Figure 5d](#F5){ref-type="fig"}--[f](#F5){ref-type="fig"}). These data thus provide support for the hypothesis that the state of extracted DNA reflects the configuration *in vivo* and that a fraction of this DNA is indeed in a nicked form. Based on the observed differential retention (a maximum of \~3-fold *in vivo*) and the maximum enhancement for fully nicked DNA (similarly found in Lin et al.^[@R28]^ and our observations), we estimate that between 1/6 and 1/3 of susceptible targets are nicked at any time *in vivo*. We note a modest difference among *in vitro* conditions (two different buffers) and the *in vivo* yeast observations. All show nicking of mismatched (and to some extent, fully matched) targets, while differences are seen in the relative proportions for different sequences. Of interest, a substantial proportion of nicked targets is observed to persist even for fully matched Cas9 targets in the yeast assays ([Figure 5b](#F5){ref-type="fig"}--[c](#F5){ref-type="fig"}, black dots).

Discussion {#S7}
==========

We show that two families of RNA-programmed CRISPR-Cas nucleases, As/Fn/Lb-Cpf1 and Cas9 can efficiently nick DNA targets with perfect and/or mismatched homology to the programming gRNA. The ability to program native CRISPR-Cas nucleases to nick has uses in technology and implications in the biology of CRISPR immunity.

The ability to tailor some CRISPR-Cas nucleases to nick at specific sites "on demand" provides a potential alternative to mutated CRISPR nuclease variants for gene editing/manipulation. While mutation of defined cleavage domains^[@R8],[@R31],[@R32]^ provides a capability for nicking activities for some CRISPR nucleases, the approach is not available for all CRISPR-Cas systems (particularly Cpf1, where a single domain may execute both cleavage reactions^[@R22],[@R33],[@R34]^). In addition, such approaches limit the multifunctional applications of CRISPR in a single system, since co-expression of nickase and wild-type enzymes will generate cleavage at intended nickase sites as well as nicking at intended cleavage sites. Use of a single wild-type enzyme with gRNAs for nicking and cleavage would surmount this challenge, with tuning of gRNAs a likely requirement in making such an approach effective. While we have not investigated such applications in microbial or other systems (e.g. mammalian cells), the use of mismatched gRNAs with wild-type CRISPR enzyme to direct nicking could be valuable for gene editing or replace nickases in gene manipulation. As an example, base editors composed of a catalytically dead Cas9 fused to a deaminase could potentially be redesigned to involve a fully functional Cas9 fused to a deaminase that can be guided to specific areas via mismatched gRNAs.

The study described here also highlights the fact that a fraction of Cas9's observed activities *in vivo* either in native systems or in engineering applications may reflect nicking rather than cleavage activities, with the balance likely dependent on *in vivo* conditions as well as the sequences of gRNAs and targets. Of particular importance here, observations that nicking activities can provide advantages in genome editing^[@R13],[@R23],[@R24],[@R26],[@R27]^ indicate that such conditions could prove advantageous. We note that the consequences of nicking will depend in each system on the kinetic balances between nick ligation, single stranded exo- and endonuclease activities that might extend or convert nicks^[@R35]^, other modes of DNA repair, and DNA replication/division rates. These kinetic parameters will vary substantially based on intrinsic cellular properties, on specific genomic positions, and on stochastic ordering of events. Of particular interest, we note recent work of Davis and Maizels^[@R13]^ provide assays for nick-induced repair and editing in mammalian systems.

An understanding of sequence requirements for nicking as well as full cleavage of targets will be critical for identification and assessment of potential off-target effects of CRISPR-Cas nucleases *in vitro* and *in vivo* as these are applied in experimental, biotechnological, and clinical settings. In particular, the existence of a guide-specific nicking repertoire impacts the selection of gRNA targets to avoid off-target consequences during genome editing. Although nicked double stranded DNA *in vivo* is less detrimental than a double stranded break, nicks lead to downstream repair events that can cause unexpected mutations (*e.g*. Kuzminov et al.^[@R25]^). Of the various algorithms that score and/or pick gRNAs based on potential off-target effects^[@R36],[@R37]^, many entail a user-selected threshold for candidate gRNA mismatch and/or leave the user to select candidate gRNAs based a mismatch-count-based estimate of off-target cleavage potential. Understanding the nicking abilities of CRISPR-Cas nucleases may thus offer considerable value in gRNA design and selection.

Imperfect homology-dependent nicking of CRISPR-Cas nucleases has implications on the mechanism of spacer acquisition in CRISPR immunity. Spacer acquisition is the process in which nucleic acids from foreign genetic elements (e.g. plasmids, bacteriophages, etc.) are integrated in the CRISPR loci. The integrated spacers are later transcribed and processed and used for host defense^[@R1],[@R38]^. Cas1 and Cas2 catalyze spacer acquisition^[@R39],[@R40]^. It has been shown that the effector CRISPR-Cas nucleases (nuclease active and inactive) in type II CRISPR systems are necessary for spacer acquisition^[@R41],[@R42]^. In addition, there is evidence that type I CRISPR-Cas systems in the presence of non-targeting gRNAs can increase spacer acquisition with evident strand bias, a phenomenon that is called "primed adaptation"^[@R43]--[@R45]^. Although primed adaptation has not been reported for the type II systems to this date, it is possible that spacer acquisition is conserved among CRISPR-Cas systems. These observations in conjunction with knowledge that nicking can be induced with mismatch gRNAs could be relevant in the increased ability to acquire spacers in the presence of a non-targeting gRNAs. In particular, the nicked product could provide a strand specific advantage for the integration of nucleic acids in the CRISPR loci. An additional possibility is that the minimal homology between the gRNA and DNA target produces a nick that serves as an anchor for the CRISPR-Cas nuclease to recruit Cas1 and Cas2.

Methods {#S8}
=======

Variant plasmid library {#S9}
-----------------------

The Cpf1 library was created using pooled oligonucleotide synthesis and was inserted into a plasmid vector population as described Fu et al.^[@R29]^. A Cas9 *unc-22A* variant library created using degenerate oligonucleotide synthesis and a library created using pooled oligonucleotide synthesis were previously characterized in Fu et al.^[@R30]^ and were used in this study. The library created by pooled oligonucleotide synthesis was retransformed and re-grown from Fu et al.^[@R30]^.

High throughput in vitro target specificity assays {#S10}
--------------------------------------------------

Cpf1 *in vitro* target specificity assays were performed as reported with Fu et al.^[@R29]^, in 100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl~2~, 100 μg/ml BSA, pH 7.9. Cpf1 gRNAs were synthesized by Integrated DNA Technologies. Each reaction contained 50 ng/ul of Cpf1 protein and gRNA at a 1:1 ratio and was incubated at 37 °C.

For Cas9, we used the modified single (chimeric) gRNA structure of Jinek et al.^[@R8]^. Target specificity *in vitro* assays for Cas9 were performed as detailed in Fu et al.^[@R29]^ (Thermo-pol buffer: 20 mM Tris-HCl, 10 mM (NH~4~)~2~SO~4~, 10 mM KCl, 2 mM MgSO~4~, 0.1% Triton X-100, pH 8.8). In addition to the buffer used for these studies, we have performed a set of parallel assays using an alternative buffer similar to that of Jinek et al.^[@R8]^ (Cas9 buffer: reaction buffer: 20 mM HEPES, 100 mM NaCl, 5 mM MgCl~2~, 0.1 mM EDTA, pH 6.5). Similar results were obtained in the two buffers, albeit (as previously observed; Fu et al.^[@R30]^) with differences in cleavage kinetics and completion.

Our initial assessment nicking and cleavage relies on the known stimulation of PCR yields from nicked plasmid as compared to circular (supercoiled) plasmids, while linearized plasmids decrease skew in PCR yields^[@R28]^. As an initial assay to assess target nicking and cleavage after Cas9/Cpf1 interaction, we start with circular plasmid libraries that carry a wide variety of target variants between defined PCR primers. Aliquots of the library are interacted with Cas9/Cpf1 and DNA extracted, along with control aliquots of the circular (unreacted) library. Each extracted DNA sample is then split into two pools, one of which is amplified and sequenced after digestion outside of the target region with a restriction enzyme that linearizes the population of molecules outside of the amplified region (so there is no longer a preference for nicked circles in overall PCR yield). The second pool is amplified without linearization, resulting in counts that would retain a preference for nicked over closed circular or double-strand cleaved molecules. We note that nicking by Cpf1/Cas9 in the amplified (target homology) region resulted in an increase of PCR yields and that both gel and PCR enhancement assays would see nicked molecules with a single cleaved phosphodiester bond in additional to molecules in which other processes had extended an initial phosphodiester break *in vitro*^[@R35]^ or *in vivo*. In practice, the observed net stimulations of PCR yields from nicking are on the order of 2^3^.

[Supplementary Table 3](#SD4){ref-type="supplementary-material"} lists gRNA and target plasmid sequences.

Calculation of retention scores {#S11}
-------------------------------

For each sequence 'X':

Retention\[X\]= log~2~(Represtentation~X~\[Library with addition of CRISPR-Cas Nuclease\]/Representation~X~\[(Uncleaved Library) or (All Variants of a specified target)\]

We normalize first to total reads from each experimental condition that have the expected length (35--36 bps) and barcode (scaling to total library counts). As an alternative normalization for comparison, we scale different libraries by counting tags matching a non-targeted gRNA sequence or all non-targeted gRNA sequences. For example, experiments with gRNAs targeting EGFP-1, EGFP-2, and *unc-22A* was normalized to the sum all variants of the *rol-6* target sequence or normalized to the sum of all non-targeted variants. For experiments where the *rol-6* was the intended target, the library was normalized to total sum of *unc-22A* variants. As expected, the different normalization approaches yield highly comparable results. Normalizations used for display are noted for each figure.

Cases of positive retention (as noted above and in \[reference to increased yield for nicked circles in PCR\]) are indicative of potential target nicking rather than cleavage. We note a maximum positive retention in our experiments of approximately 3 log-2 units, yielding a comparable estimate. A set of assays using Cas9 D10A nickase also allows us a more quantitative conversion between degree of enhancement in PCR yield and quantitative fraction of nicked templates (100% nicking yields a retention \~2.5--3, again in the same range; [Supplementary Figure 52](#SD1){ref-type="supplementary-material"}--[54](#SD1){ref-type="supplementary-material"}).

Nicking agarose gel assays {#S12}
--------------------------

Target DNA were cloned into a parent vector (pHRL-TK, Promega) using NotI and Acc65I restriction sites. Cpf1 or Cas9 reactions were set up as above for the library assays. For time points, samples were stopped with 100 mM EDTA, 2% SDS, and 80 U/μL Proteinase K and/or flash frozen with dry ice. For visualization, frozen samples were thawed and immediately loaded on \~1--1.5% agarose gel (TAE buffer, Ethidium Bromide Concentration \[0.3 mg/L\]). [Supplementary Table 3](#SD4){ref-type="supplementary-material"} lists gRNA and target plasmid sequences.

Protein components {#S13}
------------------

As/Fn/Lb-Cpf1 constructs were generated by assembly of synthetic gene fragments into an *E. coli* expression plasmid using the NEBuilder HiFi DNA Assembly Cloning Kit (NEB \#E5520S). As/Fn/Lb-Cpf1 expression vectors contained N-terminal 6xHis-tag and SV40 NLS, and C-terminal SV40 NLS. Recombinant proteins were expressed in modified *E. coli* NiCo21 (DE3) cells (NEB C2925H) harboring the Cpf1 expression plasmid by growing in LB at 23°C for 16 hr in presence of IPTG at 0.4mM. Cells were disrupted by sonication prior to chromatographic purification.

As/Fn/Lb-Cpf1 was purified using HiTrap DEAE ^FF^ (GE Healthcare), HisTrap ^HP^ (Ni-NTA) (GE Healthcare) and HiTrapSP ^HP^ (GE Healthcare) columns. Recombinant proteins were dialyzed and concentrated into 20mM Tris-HCl (pH7.4), 500mM NaCl, 1mM DTT, 0.1mM EDTA and 50% glycerol.

Cas9 and LbCpf1 protein preparations were NEB M0386S and M0653S respectively.

Cas9 in vivo assays {#S14}
-------------------

Two yeast strains were transfected with a pooled library cloned into a plasmid carrying a Cas9 expression cassette (driven by the GalL promoter), a gRNA expression construct (driven by a tetracyline inducible RPR1 promoter), and a target or non-target sequence adjacent to a potential "PAM" site ('NGG') (plasmid map available here: <https://benchling.com/s/O5VobNjd>). Target sequences are inserted into the plasmid at a defined location, with the majority deriving from a library of variants of the *unc-22A*, while variants of a sequence of unrelated origin (PS4) provide a number of internal controls^[@R29]^. The two yeast populations analyzed were from strains BY4741 (BY) and KU70 deletion strain (KU) from MATa collection. BY is an auxotrophic wild-type S288C lab strain, while KU was chosen for analysis based on its intrinsic defects in non-homologous double strand break repair. We found no major difference between the two strains. Each strain was analyzed without specific induction of Cas9 ("baseline levels"). Additionally, each strain was analyzed after one division and at 2.5 generations as assessed by optical density (these were \~90 and \~230 minutes after an initial 4-hour metabolic adaptation to galactose media from dextrose) following induction with galactose and 250 ng/ml anhydrotetracycline (ATc). Control, single-generation, and 2.5 generation time points in yeast were analyzed in duplicate for KU70, with control and single generation time points analyzed in duplicate for BY4741.

In our analysis ([Figure 5](#F5){ref-type="fig"}; [Supplementary Table 1](#SD3){ref-type="supplementary-material"}), we use the difference in log retention score for any given target (circular-linear), as the provisional metric for evaluation, validating this measurement as described. Retention scores for these comparisons are calculated from individual DNA pools that have been subdivided following extraction. One aliquot is analyzed following an experimental template-linearization cleavage step (which we call a "linear" assay a.k.a. Method 1), while a second aliquot is analyzed without such a step (designated a "circular" assay a.k.a. Method 2). As noted above, previous biochemical analysis^[@R28]^ and our further analysis *in vitro* confirm that this assessment indeed provides a metric that assesses nicking of the DNA.

Statistics and Reproducibility: {#S15}
-------------------------------

Several features of experimental design with complex libraries are key to consistent assessment of nicking activities. First, we ensure that each potential target sequence (wild-type or mutant) is present in several barcoded version in each library, allowing independent measurements for each sequence based on the individual barcodes (the number of such sequences that are used for the analysis are indicated in each figure with a value n). Second, each library contains multiple internal reference standards---plasmids with a parallel structure but with target sequences unrelated to the gRNA being assayed. For the Cas9 libraries described here, the unrelated reference sequences were from several distinct unrelated targets. As shown on the left of each line-plot figure, the relative representation of these unrelated targets was constant following interaction with a specific gRNA, while representation of targeted sequences was, as noted, consistently modulated. Additional internal control support comes from a subset of gRNA-homologous targets with central PAM variants, which also show little or no change relative to reference sequences (shown for Cpf1 targets as positions −2 and −3). Third, we carried out assessments of retention at multiple time points, and with more than one target for each enzyme, with comparable results. Cpf1 assays on each target were carried out with several different cognate enzymes and time points with similar results, Cas9 *in vitro* assays were each performed in several independent time series with comparable results, and Cas9 *in vivo* assays were performed in two different yeast strains with comparable results.

For nicking assessments using electrophoresis, all main figures ([Figure 4a](#F4){ref-type="fig"}--[e](#F4){ref-type="fig"}) gRNA::target combination was tested at multiple time points, with multiple experimental trials; for [Supplemental Figures 28](#SD1){ref-type="supplementary-material"}--[33](#SD1){ref-type="supplementary-material"} and [48](#SD1){ref-type="supplementary-material"}--[51](#SD1){ref-type="supplementary-material"}, a single series with multiple time points was carried out. In each case, an expected migration shift on nicking was observed.

Data availability {#S16}
-----------------

The raw data that support our findings is available in Short Reads Archive: PRJNA503740 (see [Supplementary Table 2](#SD1){ref-type="supplementary-material"} for information on data for each corresponding figure).
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![High throughput assay for nicking and cleavage by CRISPR-Cas nucleases.\
a) Schematic of *in vitro* high throughput plasmid libraries and subsequent steps used to assess representation or each sequence before and after CRISPR-Cas interaction. Each library consists of a uniform backbone into which a variety of potential target sites are inserted at a single location. Potential targets match one of several gRNA or control sequences (panel b); with each library including a diversity of both matched and mismatched sequences. To assess representation for each sequence before and after CRISPR-Cas interaction, samples were amplified with primers flanking the potential cleavage site and subjected to high throughput sequencing. Amplification and sequencing of an unreacted sample (no CRISPR-Cas interaction) provides a baseline fraction of normalization of each variant; this reference amplification and sequencing is carried out for every experiment and used for subsequent normalization. To assess topological state before and after CRISPR-Cas interaction, samples were split into two pools that are treated identically with the exception that one of the two subpools is cleaved at a site outside of the region to be amplified ("Method 1"), while the other pool is not subjected an outside cleavage ("Method 2"). Amplification of uncleaved circular templates (Method 2) is known to enrich for nicked over closed circular templates^[@R28]^.\
b) Depiction of target sequences synthesized for the Cpf1 and Cas9 variant libraries. Regions in red indicate the PAM, blue indicates seed region (positions 1--10), green indicates the distal region (positions 11--20), and magenta is the barcode region. For each target, the following variants were synthesized: wild-type, single variants, single deletions, and double consecutive transversion variants.](nihms-1519300-f0001){#F1}

![Library-based assessment of nicking and cleavage activities of LbCpf1 on single mutant target variants.\
Line graphs on left show retention profiles for whole-library assays with a post-reaction backbone cleavage step that avoid preferential recovery of nicked substrates. Line graphs on right show retention profiles without such a cleavage step (i.e., with preferential recovery of nicked sequences). For the assays shown in this figure, nuclease LbCpf1 was programmed with an EGFP-1 gRNA and interacted with a mixed target library as described in [Figure 1a](#F1){ref-type="fig"}. Retention scores are shown for single base transversions at each indicated position in the EGFP-1 target, and have been normalized using median retention for a set of unrelated target sequences included in the library \[*unc-22A*, *rol-6*, and EGFP-2\]) (Sequencing Data: AF_SOL_820; For details on retention score calculation, see "[Materials and Methods](#S8){ref-type="sec"}".).](nihms-1519300-f0002){#F2}

![Library-based assessment of nicking and cleavage activities of LbCpf1 on double consecutive transversion and deletion target variants.\
Bar graphs on left show retention profiles for whole-library assays with a post-reaction backbone cleavage step that avoid preferential recovery of nicked substrates. Bar graphs on right show retention profiles without such a cleavage step (i.e., with preferential recovery of nicked sequences). a) Single deletion variants, b) Double consecutive transversion variants. Bar graphs show median retention of indicated variants at each base, with error bars representing the standard deviation of observed retention among distinct barcoded instances of each variant target sequence. (Left: linearized library; Right: circular library) (Sequence Data: AF_SOL_820; For details on retention score calculation, see "[Materials and Methods](#S8){ref-type="sec"}".). Number of distinct barcoded instances for each variant assessed (n for standard deviation calculation) were as follows: Left: WT: 26, Deletions 1--12: 7, 9, 8, 9, 6, 3, 10, 2, 6, 6, 3, 6. Consecutive Transversions 1--19: 19, 24, 11, 4, 5, 8, 7, 6, 6, 9, 9, 5, 8, 11, 7, 8, 8, 5, 5. Right: WT: 24, Deletions 1--12: 6, 8, 8, 9, 6, 4, 6,1, 5, 6, 2, 5, Consecutive Transversions 1--19: 15, 20, 9, 5, 3, 8, 5, 5, 8, 9, 9, 6, 9, 11, 6, 6, 5, 5, 4.](nihms-1519300-f0003){#F3}

![Gel-based assessments of nicking and cleavage by LbCpf1 and Cas9.\
**a-c)** Gel-based assays for nicking by LbCpf1. **a)** Left: Wild-type EGFP-1 target (p648) reacted with wild-type EGFP-1 gRNA. Gels show a mixture of linear, nicked, and uncut target plasmids, Right: a mutated EGFP-1 target (p703) with wild-type EGFP-1 gRNA showed preferential accumulation of nicked plasmid. **b)** Gel assay with mutated EGFP-1 target (p705) and wild-type EGFP-1 gRNA. Preferential nicking with some linearization is observed. **c)** Specificity assessment using nicking gel assay. Tested gRNAs are wild-type *unc-22A (u22)* and mismatched EGFP*-1* (Mis1). Tested targets are wild-type *unc-22A* (p658) and EGFP-1 (p648*)*. The u22 gRNA linearizes the wild-type *unc-22A* (p658) target while having no effect on the EGFP-1 (p648) target. The mismatched EGFP-1 gRNA (Mis1) promotes nicking when paired with the EGFP-1 target but not with *unc-22A*. Nicking is thus shown to be RNA-guided and specific. **d), e)** Specificity and mismatch effects on Cas9 nicking and cleavage activities. **d)** Cas9 activity wild-type *unc-22A* gRNA and mutated *unc-22A* target (left), and with wild-type *unc-22A* gRNA and wild-type *unc-22A* target (right). Cas9 can be seen to efficiently nick at the mismatched target. **e)** Wild-type EGFP-2 gRNA with mutated EGFP-2 DNA targets (p775 and p777) and wild-type EGFP-2 with wild-type EGFP-2 DNA (middle). Both mutated EGFP-2 targets are nicked efficiently. The p775 mutation if given enough time eventually linearizes the plasmid (left). The p777 mutation remains nicked through the time course (right).](nihms-1519300-f0004){#F4}

![Assays for target-match-dependent nicking of precise and imprecise targets by Cas9 *in vivo*.\
**a)** Reproducible nicking signal for matched targets following Cas9 induction in yeast. This plot compares differential retention\
\[log2(circular_assay_retention) - log2(linear_assay_retention)\] for induced libraries from two different but functionally equivalent yeast strains, BY4741 and ΔKU70. Individual dots represent different target sequences, each assessed as a median over multiple barcoded instances in each library. Targets unrelated to *unc-22A* (grey hollow circles; "Protospacer 4" variants^[@R29]^) and with perfect *unc-22A* match in the gRNA homology but mismatches in the GG pam (blue squares) show no substantial differential retention in either sample. Perfectly matched targets with canonical "NGG" PAM sites (black circle) show substantial differential retention in the two yeast populations. Targets with single mismatch (red dots) show a spectrum of different retention differentials, ranging from no difference to differences comparable to the perfect target match. The two yeast populations give highly similar results with calculated sample-to-sample correlations between the two yeast populations of 0.81 (Pearson; two-tailed p-value=9.6E-17, n=66), and 0.76 (Spearman; two-tailed p-value=1.6E-13, n=66). For details on retention score calculation, see "[Materials and Methods](#S8){ref-type="sec"}". **b-e)** Similar sequence requirements for nicked substrate accumulation under diverse *in vitro* and *in vivo* conditions. Top graphs show circular and linear assay retention scores for yeast (*in vivo*) experiments in the BY4741 and ΔKU70 genetic backgrounds. Each plot shows median retention for multiple (barcoded) transversion variants at each position (averaged where duplicate sample are available for the relevant conditions). Retentions are calculated using the unrelated PS4 sequence as an internal standard, with initial library abundance obtained from measurement of target species incidence in parallel libraries with yeast that have not been induced. Below are equivalent retention score plots for *in vitro* analysis in which an equivalent library of targets was interacted with purified Cas9 in one of two buffer conditions (a relatively active "Thermo-Pol" buffer condition and a less active "Cas9 buffer" condition; see [methods](#S8){ref-type="sec"} for buffer details). **f)** Differential retention comparison between *in vitro* and *in vivo* samples. The *in vivo* sample shown here is from BY4741 (at 2.5 generations) compared to the initial rate (1 minute) of nicking *in vitro* (Cas9 buffer). Correlations are Pearson: 0.54, two-tailed p-value=3.6E-6 and Spearman 0.49, two-tailed p-value=3.2E-5 (n=66). Each point on the plot represents a single gRNA homology+PAM sequence class, showing a median of differential retentions derived from independent flanking-barcoded instances of each sequence.](nihms-1519300-f0005){#F5}
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